Bone Disorders

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2023-06-01
EMA Authorised: Zoledronic acid Actavis (zoledronic acid monohydrate) — Actavis Group PTC ehf
The EMA authorised Zoledronic acid Actavis (zoledronic acid monohydrate) for therapeutic use in fractures and bone-related conditions.